Dr. Philip Berman, MD FACC
What this data tells you about Dr. Berman
Dr. Philip Berman is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Berman performed 4,750 Medicare services across 3,523 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berman received a total of $42,993 from 55 pharmaceutical and/or device companies across 803 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,132 | $92 | $250 |
| Electrocardiogram (EKG), 12-lead | 833 | $10 | $80 |
| EKG interpretation and report | 629 | $7 | $40 |
| Office visit, established patient (20-29 min) | 508 | $67 | $200 |
| Echocardiogram, transthoracic | 425 | $151 | $800 |
| Regadenoson injection (Lexiscan) for heart stress test | 206 | $44 | $90 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 117 | $80 | $464 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 114 | $351 | $2,200 |
| Hospital follow-up visit, high complexity | 100 | $96 | $315 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 87 | $48 | $250 |
| New patient office visit (45-59 min) | 87 | $126 | $275 |
| Ultrasound of both sides of head and neck blood flow | 86 | $144 | $550 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 58 | $197 | $900 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 55 | $10 | $150 |
| Initial hospital admission, moderate complexity | 46 | $102 | $300 |
| New patient office visit (30-44 min) | 43 | $83 | $200 |
| Cardiac catheterization | 41 | $218 | $2,200 |
| Initial hospital admission, high complexity | 38 | $136 | $450 |
| Hospital follow-up visit, moderate complexity | 35 | $64 | $264 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 33 | $14 | $100 |
| Remote pacemaker monitoring, 90 days | 23 | $24 | $85 |
| Office visit, established patient, complex (40-54 min) | 23 | $132 | $293 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 18 | $223 | $2,500 |
| Office visit, established patient (10-19 min) | 13 | $42 | $175 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Berman is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 18% in TX), and high industry engagement (speaking/promotional, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Berman experienced with office visit, established patient (30-39 min)?
Does Dr. Berman receive payments from pharmaceutical companies?
How do Dr. Berman's costs compare to other cardiovascular diseases in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology